×
About 598 results

ALLMedicine™ Oral Infections Center

Research & Reviews  195 results

Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
https://clinicaltrials.gov/ct2/show/NCT01568697

Jan 26th, 2023 - This is a cross sectional/natural history protocol designed to investigate the clinical, microbiologic, and immunologic consequences of genetic immune defects in the oral cavity. The hypothesis is that genetic immune defects will lead to alteratio...

Managing Oral Health in the Context of Antimicrobial Resistance.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778414
International Journal of Environmental Research and Publi... Bessa LJ, Botelho J et. al.

Dec 24th, 2022 - The oral microbiome plays a major role in shaping oral health/disease state; thus, a main challenge for dental practitioners is to preserve or restore a balanced oral microbiome. Nonetheless, when pathogenic microorganisms install in the oral cavi...

Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
https://clinicaltrials.gov/ct2/show/NCT05654129

Dec 16th, 2022 - Non-alcoholic fatty liver disease is becoming the leading cause of chronic liver disease with a prevalence of 20% worldwide. The prognosis depends on the degree of fibrosis: patients with a low degree of fibrosis (F0-F2) have a good prognosis unli...

Electrolyzed water for the microbiologic control in the pandemic dental setting: a syst...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733258
BMC Oral Health; Cárdenas AM, Campos-Bijit V et. al.

Dec 10th, 2022 - Electrolyzed water has brought recent attention due to its antimicrobial properties. Indeed, electrolyzed water has been proposed to sterilize dental materials and instruments without compromising their structural integrity. In addition, electroly...

Polyphenols and Lactobacillus reuteri in oral health.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710395
Journal of Preventive Medicine and Hygiene; Naureen Z, Medori MC et. al.

Dec 9th, 2022 - Oral health is one of the necessary preludes to the overall quality of life. Several medical procedures and therapies are available to treat oral diseases in general and periodontal diseases in particular, yet caries, periodontitis, oral cancer, a...

see more →

Clinicaltrials.gov  23 results

Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
https://clinicaltrials.gov/ct2/show/NCT01568697

Jan 26th, 2023 - This is a cross sectional/natural history protocol designed to investigate the clinical, microbiologic, and immunologic consequences of genetic immune defects in the oral cavity. The hypothesis is that genetic immune defects will lead to alteratio...

Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
https://clinicaltrials.gov/ct2/show/NCT05654129

Dec 16th, 2022 - Non-alcoholic fatty liver disease is becoming the leading cause of chronic liver disease with a prevalence of 20% worldwide. The prognosis depends on the degree of fibrosis: patients with a low degree of fibrosis (F0-F2) have a good prognosis unli...

Bariatric Surgery: Microbiome & Diabetes
https://clinicaltrials.gov/ct2/show/NCT03723486

Nov 2nd, 2022 - Morbid obesity is associated with not only type 2 diabetes (T2D) of morbidly obese patients), but also cardiovascular complications, all of which remarkably improved and even resolved with bariatric surgery, of which the RYGB surgery has become th...

Influence of Lateral Pressure on Sectional Matrix
https://clinicaltrials.gov/ct2/show/NCT05423639

Jul 20th, 2022 - Dental caries is considered as one of the most prevalent oral infections. Initiation of dental caries is a mufti-factorial process, its risk factors includes high loads of cariogenic bacteria, increased frequency of sugar intake, insufficient expo...

Hyperbaric Oxygen and Its Effect on Radiation Induced Long Term Side Effects
https://clinicaltrials.gov/ct2/show/NCT02450305

May 5th, 2022 - Radiation therapy is a commonly utilized treatment modality for head and neck cancer patients. Xerostomia (i.e. dry mouth) (and taste change) are common and most significant side effects of this treatment. Xerostomia leads to several complications...

see more →

News  21 results

Gum Disease-Afib Link Deepened by Histologic Findings
https://www.medpagetoday.com/cardiology/arrhythmias/101509

Oct 31st, 2022 - Growing evidence suggests periodontitis as a possible modifiable risk factor for atrial fibrillation (Afib), though left unanswered is the question of whether improving oral health can help clinical outcomes. A histologic association between infla...

Warning on Dissolving Buprenorphine; FDA OKs Rexulti in Teens; Psychiatrist Salaries
https://www.medpagetoday.com/psychiatry/generalpsychiatry/96634

Jan 12th, 2022 - The FDA issued a warning over possible dental problems -- including tooth decay, cavities, oral infections, and loss of teeth -- with orally dissolving medications containing buprenorphine used for the treatment of opioid use disorder and pain. Ho...

2017 ASCO Annual Meeting Presscast
https://www.onclive.com/view/2017-asco-annual-meeting-presscast

Apr 2nd, 2021 - Today- Highlights from a presscast held ahead of the 2017 ASCO Annual Meeting. Welcome to OncLive News Network! I’m Gina Columbus. Phase III results showed that adjuvant gefitinib reduced the risk of disease recurrence by 40% versus stand...

HPV Vaccine Reduced High-Risk Oral Infections by Nearly 90%, but Poor Uptake Limits Impact
https://www.onclive.com/view/hpv-vaccine-reduced-highrisk-oral-infections-by-nearly-90-but-poor-uptake-limits-impact

Dec 20th, 2020 - Maura L. Gillison, MD, PhD The efficacy of the human papillomavirus (HPV) vaccine continues to be impressive, with newly reported findings showing that it reduced the prevalence of high-risk oral HPV infections by 88% in young adults who had at l...

ASCO Panel Sees Greater Utility for Bone-Modifying Agents in Myeloma
https://www.onclive.com/view/asco-panel-sees-greater-utility-for-bonemodifying-agents-in-myeloma

Dec 5th, 2020 - Kenneth C. Anderson, MD In updated guidelines exploring the role of bone-modifying agents, the American Society of Clinical Oncology (ASCO) has recommended expanding the use of bisphosphonates to include all patients being treated for active mult...

see more →